Posted by Michael Wonder on 26 Aug 2024
FDA clears first device to enable automated insulin dosing for individuals with type 2 diabetes
26 August 2024 - Agency supports broader access to innovative technology in diabetes management.
Today, the US FDA expanded the indications of the Insulet SmartAdjust technology, an interoperable automated glycemic controller previously indicated for the management of type 1 diabetes in individuals two years and older, to also include management of type 2 diabetes in individuals 18 years and older.
